DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model.
The DltABCD and MprF proteins contribute a net positive charge to the Staphylococcus aureus surface envelope by alanylating and lysinylating teichoic acids and membrane phosphatidylglycerol, respectively. These surface charge modifications are associated with increased in vitro resistance profiles of S. aureus to a number of endogenous cationic antimicrobial peptides (CAPs), such as alpha-defensins. The current study investigated the effects of dltA and mprF mutations on the following host factors relevant to endovascular infections: (i) in vitro susceptibility to the CAP thrombin-induced platelet microbicidal protein 1 (tPMP-1), (ii) in vitro adherence to endothelial cells (EC) and matrix proteins, and (iii) in vivo virulence in an endovascular infection model (rabbit endocarditis) in which tPMP-1 is felt to play a role in limiting S. aureus pathogenesis. Both mutations resulted in substantial increases in the in vitro susceptibility to tPMP-1 compared to that of the parental strain. The dltA (but not the mprF) mutation resulted in a significantly reduced capacity to bind to EC in vitro, while neither mutation adversely impacted in vitro binding to fibronectin, fibrinogen, or platelets. In vivo, both mutations significantly attenuated virulence in terms of early colonization of sterile vegetations and subsequent proliferation at this site (versus the parental strain). However, only the dltA mutation significantly reduced metastatic infections in kidneys and spleens compared to those in animals infected with the parental strain. These data underscore the importance of resistance to distinct CAPs and of teichoic acid-dependent EC interactions in the context of endovascular infection pathogenesis.
Weidenmaier
Christopher
C
Cellular and Molecular Microbiology Division, Medical Microbiology and Hygiene Department, University of Tübingen, 72076 Tübingen, Germany.
Peschel
Andreas
A
Kempf
Volkhard A J
VA
Lucindo
Natalie
N
Yeaman
Michael R
MR
Bayer
Arnold S
AS
D019881:Aminoacyltransferases; D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics*; D001798:Blood Proteins / Q000494:pharmacology; D002448:Cell Adhesion; D002462:Cell Membrane / Q000235:genetics; D004195:Disease Models, Animal; D024881:Drug Resistance, Bacterial / Q000235:genetics; D004697:Endocarditis, Bacterial / Q000382:microbiology*; D042783:Endothelial Cells / Q000382:microbiology; D005340:Fibrinogen / Q000378:metabolism; D005353:Fibronectins / Q000378:metabolism; D017353:Gene Deletion; D008565:Membrane Proteins / Q000235:genetics*; D009154:Mutation; D011817:Rabbits; D013203:Staphylococcal Infections / Q000150:complications / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity*; D013682:Teichoic Acids / Q000235:genetics; D014774:Virulence / Q000235:genetics
D001426:Bacterial Proteins; D001798:Blood Proteins; D005353:Fibronectins; D008565:Membrane Proteins; D013682:Teichoic Acids; C077150:platelet microbicidal protein, Oryctolagus cuniculus; D005340:Fibrinogen; D019881:Aminoacyltransferases; C429146:mprF protein, Staphylococcus aureus